Google Deep Mind Stock Price

ai, Google and Isomorphic Labs

Isomorphic Labs, Google’s A.I. Drug Business, Raises $600 Million

The company, which uses artificial intelligence to develop new treatments, now counts the venture capital firm Thrive Capital as a backer.

The Financial Times on MSN · 20h

Google DeepMind’s drug discovery spin-off Isomorphic Labs raises $600mn

Isomorphic Labs, the drug discovery start-up spun out of Google’s DeepMind artificial intelligence unit, has raised $600mn in its first external funding round, as investors bet on the potential for AI to “solve disease”.

U.S. News & World Report · 22h

Google-Backed AI Drug Discovery Startup Raises $600 Million

Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup said on Monday.

5don MSN

Google stock price forecast: Elon Musk’s Grok is a top threat

The Google stock price has crashed into a bear market this year as concerns about the technology industry continues. After ...

Investing19d

Google DeepMind unveils Gemini Robotics, a new AI model for advanced robotics

Investing.com -- Google (NASDAQ:GOOGL) DeepMind has announced the introduction of two new artificial intelligence models, Gemini Robotics and Gemini Robotics-ER, both based on the Gemini 2.0 ...

13d

Nvidia (NVDA) Teams Up with Disney and Google to Build Smarter Robots

At its GTC 2025 keynote, Nvidia (NVDA) CEO Jensen Huang announced a major partnership with Walt Disney (DIS) and Google DeepMind to develop smarter robots. The three companies are working on Newton, a ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

ai, Google and Isomorphic Labs

Trending now